You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

upadacitinib

Showing 1 - 25 of 44
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Upadacitinib of Enthesitis Evaluated by Ultrasound in Psoriatic

Not yet recruiting
  • Psoriatic Arthritis
  • Upadacitinib
  • Madrid, Spain
    Instituto de Investigación Sanitaria Fundación Jiménez Díaz
Nov 25, 2023

Crohn Disease Trial (Upadacitinib, Vedolizumab)

Not yet recruiting
  • Crohn Disease
  • (no location specified)
Oct 18, 2023

Vitiligo Trial (Upadacitinib, Placebo)

Not yet recruiting
  • Vitiligo
  • Upadacitinib
  • Placebo
  • (no location specified)
Nov 1, 2023

Alopecia Areata Trial (Upadacitinib, Placebo)

Not yet recruiting
  • Alopecia Areata
  • Upadacitinib
  • Placebo
  • (no location specified)
Aug 22, 2023

Hidradenitis Suppurativa Trial (Upadacitinib, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • Upadacitinib
  • Placebo
  • (no location specified)
May 26, 2023

Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)

Not yet recruiting
  • Juvenile Idiopathic Arthritis
  • (no location specified)
Nov 7, 2022

Application of N-of-1 Rheumatoid Arthritis

Not yet recruiting
  • Arthritis, Rheumatoid
  • Boston, Massachusetts
    Tufts Medical Center
Aug 24, 2023

Atopic Dermatitis (AD) Trial (Upadacitinib)

No longer available
  • Atopic Dermatitis (AD)
  • Upadacitinib
  • (no location specified)
Aug 2, 2021

Molecular Signatures in Inflammatory Skin Disease

Recruiting
  • Atopic Dermatitis
  • Psoriasis
  • Kiel, Germany
    Department of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022

Atopic Dermatitis (AD) Trial (Upadacitinib, Placebo for Upadacitinib)

Withdrawn
  • Atopic Dermatitis (AD)
  • Upadacitinib
  • Placebo for Upadacitinib
  • (no location specified)
Apr 7, 2021

Hidradenitis Suppurativa (HS) Trial in Worldwide (Upadacitinib, Placebo Upadacitinib)

Completed
  • Hidradenitis Suppurativa (HS)
  • Upadacitinib
  • Placebo Upadacitinib
  • Phoenix, Arizona
  • +25 more
Mar 22, 2022

Atopic Dermatitis Trial in Japan (Upadacitinib, Placebo for upadacitinib, Topical Corticosteroids (TCS))

Completed
  • Atopic Dermatitis
  • Upadacitinib
  • +2 more
  • Ichinomiya-shi, Aichi, Japan
  • +42 more
Sep 6, 2022

Non-Segmental Vitiligo Trial in Worldwide (Upadacitinib, Placebo)

Active, not recruiting
  • Non-Segmental Vitiligo
  • Upadacitinib
  • Placebo
  • Irvine, California
  • +34 more
Jan 31, 2023

Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)

Recruiting
  • Takayasu Arteritis (TAK)
  • Upadacitinib
  • +2 more
  • Salvador, Bahia, Brazil
  • +44 more
Aug 22, 2022

Rheumatoid Arthritis Trial (Upadacitinib, Adalimumab)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Nov 29, 2021

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021

Assess Disease Activity in Adult Ankylosing Spondylitis Who

Recruiting
  • Radiographic Axial Spondylarthritis (r-axSpA)
  • Upadacitinib
  • Ulm, Baden-Wuerttemberg, Germany
  • +69 more
Aug 8, 2022

Ulcerative Colitis Trial in Worldwide (Upadacitinib)

Not yet recruiting
  • Ulcerative Colitis
  • Upadacitinib
  • Boston, Massachusetts
  • +62 more
Mar 13, 2023

Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Upadacitinib
  • +7 more
  • Birmingham, Alabama
  • +7 more
Sep 19, 2022

Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Upadacitinib
  • Placebo
  • Curitiba, Parana, Brazil
  • +42 more
Aug 30, 2021

Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Upadacitinib, Placebo Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +152 more
Aug 30, 2022

Systemic Lupus Erythematosus Trial in Worldwide (Upadacitinib, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Upadacitinib
  • Placebo
  • Flagstaff, Arizona
  • +257 more
Apr 25, 2023

Atopic Dermatitis Trial in Worldwide (Upadacitinib)

Active, not recruiting
  • Atopic Dermatitis
  • Upadacitinib
  • Little Rock, Arkansas
  • +115 more
Jul 27, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo to Upadacitinib, Methotrexate, Placebo to Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo to Upadacitinib
  • +3 more
  • La Mesa, California
  • +289 more
Dec 1, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Adalimumab, Upadacitinib Matching Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Upadacitinib
  • +3 more
  • Flagstaff, Arizona
  • +190 more
Apr 4, 2023